AIMD logo

AIMD Ainos, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$1.35
+0.05 (+4.08%)

Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications. Other diagnostic…

Market Cap: $9.96Mwww.ainos.com

Price

No data yet.

Social Signal Score

46
5d
—
30d
44
7 mentions
—
60d
47
12 mentions
—
90d
47
12 mentions
—
news: 12

Revenue

$152.00
$-4.4K$583.0K$1.17M$1.76M
Sep 2016Jun 2026

Company Profile

CEO
Chun-Hsien Tsai
Sector
Healthcare
Industry
Biotechnology
Employees
41
Beta
2.48
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-8.15
www.ainos.com